Coloplast Valuation
| CBHD Stock | EUR 64.54 0.42 0.65% |
At this time, the firm appears to be overvalued. Coloplast AS shows a prevailing Real Value of €55.87 per share. The current price of the firm is €64.54. Our model approximates the value of Coloplast AS from analyzing the firm fundamentals such as Profit Margin of 0.14 %, return on equity of 0.27, and Current Valuation of 17.72 B as well as examining its technical indicators and probability of bankruptcy.
Price Book 7.9239 | Enterprise Value 17.7 B | Enterprise Value Ebitda 15.8356 | Price Sales 0.5215 | Forward PE 19.0114 |
Overvalued
Today
Please note that Coloplast's price fluctuation is very steady at this time. Calculation of the real value of Coloplast AS is based on 3 months time horizon. Increasing Coloplast's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Coloplast stock is determined by what a typical buyer is willing to pay for full or partial control of Coloplast AS. Since Coloplast is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Coloplast Stock. However, Coloplast's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 64.54 | Real 55.87 | Hype 64.21 | Naive 66.65 |
The real value of Coloplast Stock, also known as its intrinsic value, is the underlying worth of Coloplast AS Company, which is reflected in its stock price. It is based on Coloplast's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Coloplast's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Coloplast AS helps investors to forecast how Coloplast stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Coloplast more accurately as focusing exclusively on Coloplast's fundamentals will not take into account other important factors: Coloplast Cash |
|
Coloplast Total Value Analysis
Coloplast AS is currently forecasted to have takeover price of 17.72 B with market capitalization of 14.55 B, debt of 5.08 B, and cash on hands of 143.67 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Coloplast fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.72 B | 14.55 B | 5.08 B | 143.67 M |
Coloplast Investor Information
About 30.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.38. Coloplast AS last dividend was issued on the 5th of December 2025. The entity had 5:1 split on the 19th of December 2012. Based on the key indicators related to Coloplast's liquidity, profitability, solvency, and operating efficiency, Coloplast AS is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 4.4 B | 3.2 B |
|
| |||||
| Operating Income | 6.3 B | 8.4 B |
|
|
Coloplast Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Coloplast has an asset utilization ratio of 56.23 percent. This implies that the Company is making €0.56 for each dollar of assets. An increasing asset utilization means that Coloplast AS is more efficient with each dollar of assets it utilizes for everyday operations.Coloplast Profitability Analysis
Based on Coloplast's profitability indicators, Coloplast AS may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Coloplast's ability to earn profits and add value for shareholders.Net Income | First Reported 2017-03-31 | Previous Quarter 805 M | Current Value 1.4 B | Quarterly Volatility 154.1 M |
For Coloplast profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Coloplast AS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Coloplast utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Coloplast's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Coloplast over time as well as its relative position and ranking within its peers.
Coloplast Earnings per Share Projection vs Actual
By analyzing Coloplast's earnings estimates, investors can diagnose different trends across Coloplast's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Coloplast AS is based on EPS before non-recurring items and includes expenses related to employee stock options.Coloplast Ownership Allocation
Coloplast holds a total of 207.37 Million outstanding shares. Coloplast AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Coloplast Profitability Analysis
The company reported the revenue of 27.03 B. Net Income was 5.05 B with profit before overhead, payroll, taxes, and interest of 18.93 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Coloplast's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Coloplast and how it compares across the competition.
About Coloplast Valuation
The stock valuation mechanism determines Coloplast's current worth on a weekly basis. Our valuation model uses a comparative analysis of Coloplast. We calculate exposure to Coloplast's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Coloplast's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 21 B | 13.8 B |
Coloplast Quarterly Retained Earnings |
|
Complementary Tools for Coloplast Stock analysis
When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |